Subsonic stability and control derivatives for an unpowered, remotely piloted 3/8-scale F-15 airplane model obtained from flight test

In response to the interest in airplane configuration characteristics at high angles of attack, an unpowered remotely piloted 3/8-scale F-15 airplane model was flight tested. The subsonic stability and control characteristics of this airplane model over an angle of attack range of -20 to 53 deg are documented. The remotely piloted technique for obtaining flight test data was found to provide adequate stability and control derivatives. The remotely piloted technique provided an opportunity to test the aircraft mathematical model in an angle of attack regime not previously examined in flight test. The variation of most of the derivative estimates with angle of attack was found to be consistent, particularly when the data were supplemented by uncertainty levels

A comparison of hypersonic vehicle flight and prediction results

Aerodynamic and aerothermodynamic comparisons between flight and ground test for four hypersonic vehicles are discussed. The four vehicles are the X-15, the Reentry F, the Sandia Energetic Reentry Vehicle Experiment (SWERVE), and the Space Shuttle. The comparisons are taken from papers published by researchers active in the various programs. Aerodynamic comparisons include reaction control jet interaction on the Space Shuttle. Various forms of heating including catalytic, boundary layer, shock interaction and interference, and vortex impingement are compared. Predictions were significantly exceeded for the heating caused by vortex impingement (on the Space Shuttle OMS pods) and for heating caused by shock interaction and interference on the X-15 and the Space Shuttle. Predictions of boundary-layer state were in error on the X-15, the SWERVE, and the Space Shuttle vehicles

Extraction of stability and control derivatives from orbiter flight data

The Space Shuttle Orbiter has provided unique and important information on aircraft flight dynamics. This information has provided the opportunity to assess the flight-derived stability and control derivatives for maneuvering flight in the hypersonic regime. In the case of the Space Shuttle Orbiter, these derivatives are required to determine if certain configuration placards (limitations on the flight envelope) can be modified. These placards were determined on the basis of preflight predictions and the associated uncertainties. As flight-determined derivatives are obtained, the placards are reassessed, and some of them are removed or modified. Extraction of the stability and control derivatives was justified by operational considerations and not by research considerations. Using flight results to update the predicted database of the orbiter is one of the most completely documented processes for a flight vehicle. This process followed from the requirement for analysis of flight data for control system updates and for expansion of the operational flight envelope. These results show significant changes in many important stability and control derivatives from the preflight database. This paper presents some of the stability and control derivative results obtained from Space Shuttle flights. Some of the limitations of this information are also examined

Space Shuttle hypersonic aerodynamic and aerothermodynamic flight research and the comparison to ground test results

Aerodynamic and aerothermodynamic comparisons between flight and ground test for the Space Shuttle at hypersonic speeds are discussed. All of the comparisons are taken from papers published by researchers active in the Space Shuttle program. The aerodynamic comparisons include stability and control derivatives, center-of-pressure location, and reaction control jet interaction. Comparisons are also discussed for various forms of heating, including catalytic, boundary layer, top centerline, side fuselage, OMS pod, wing leading edge, and shock interaction. The jet interaction and center-of-pressure location flight values exceeded not only the predictions but also the uncertainties of the predictions. Predictions were significantly exceeded for the heating caused by the vortex impingement on the OMS pods and for heating caused by the wing leading-edge shock interaction

The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance

Summary: The calibrated population resistance (CPR) tool is a web-accessible program for performing standardized genotypic estimation of transmitted HIV-1 drug resistance. The program is linked to the Stanford HIV drug resistance database and can additionally perform viral genotyping and algorithmic estimation of resistance to specific antiretroviral drugs

Identification of an envelope mutation (env-10) resulting in increased antibiotic susceptibility and pyocin resistance in a clinical isolate of Neisseria gonorrhoeae.

A mutation (env-10) conferring increased susceptibility to drugs, dyes, and detergents was detected in a clinical isolate of Neisseria gonorrhoeae. In certain strains, env-10 also affected susceptibility to pyocins. This mutation was phenotypically similar to but genotypically distinct from previously described env mutations

Plasma Perturbations and Cosmic Microwave Background Anisotropy in the Linearly Expanding Milne-like Universe

We expose the scenarios of primordial baryon-photon plasma evolution within the framework of the Milne-like universe models. Recently, such models find a second wind and promise an inflation-free solution of a lot of cosmological puzzles including the cosmological constant one. Metric tensor perturbations are considered using the five-vectors theory of gravity admitting the Friedmann equation satisfied up to some constant. The Cosmic Microwave Background (CMB) spectrum is calculated qualitatively.Comment: 20 page

Natural variation of HIV-1 group M integrase: Implications for a new class of antiretroviral inhibitors

HIV-1 integrase is the third enzymatic target of antiretroviral (ARV) therapy. However, few data have been published on the distribution of naturally occurring amino acid variation in this enzyme. We therefore characterized the distribution of integrase variants among more than 1,800 published group M HIV-1 isolates from more than 1,500 integrase inhibitor (INI)-naïve individuals. Polymorphism rates equal or above 0.5% were found for 34% of the central core domain positions, 42% of the C-terminal domain positions, and 50% of the N-terminal domain positions. Among 727 ARV-naïve individuals in whom the complete pol gene was sequenced, integrase displayed significantly decreased inter- and intra-subtype diversity and a lower Shannon's entropy than protease or RT. All primary INI-resistance mutations with the exception of E157Q – which was present in 1.1% of sequences – were nonpolymorphic. Several accessory INI-resistance mutations including L74M, T97A, V151I, G163R, and S230N were also polymorphic with polymorphism rates ranging between 0.5% to 2.0%

2022 update of the drug resistance mutations in HIV-1

The 2022 edition of the IAS-USA drug resistance mutations list updates the Figure last published in September 2019. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The Figure is designed to assist practitioners to identify key mutations associated with resistance to antiretroviral drugs, and therefore, in making clinical decisions regarding antiretroviral therapy

Trends in genotypic HIV-1 antiretroviral resistance between 2006 and 2012 in South African patients receiving first- and second-line antiretroviral treatment regimens

The original publication is available at http://www.plosone.org/Publication of this article was funded by the Stellenbosch University Open Access Fund.BibliographyObjectives: South Africa’s national antiretroviral (ARV) treatment program expanded in 2010 to include the nucleoside reverse transcriptase (RT) inhibitors (NRTI) tenofovir (TDF) for adults and abacavir (ABC) for children. We investigated the associated changes in genotypic drug resistance patterns in patients with first-line ARV treatment failure since the introduction of these drugs, and protease inhibitor (PI) resistance patterns in patients who received ritonavir-boosted lopinavir (LPV/r)-containing therapy. Methods: We analysed ARV treatment histories and HIV-1 RT and protease mutations in plasma samples submitted to the Tygerberg Academic Hospital National Health Service Laboratory. Results: Between 2006 and 2012, 1,667 plasma samples from 1,416 ARV-treated patients, including 588 children and infants, were submitted for genotypic resistance testing. Compared with 720 recipients of a d4T or AZT-containing first-line regimen, the 153 recipients of a TDF-containing first-line regimen were more likely to have the RT mutations K65R (46% vs 4.0%; p<0.001), Y115F (10% vs. 0.6%; p<0.001), L74VI (8.5% vs. 1.8%; p<0.001), and K70EGQ (7.8% vs. 0.4%) and recipients of an ABC-containing first-line regimen were more likely to have K65R (17% vs 4.0%; p<0.001), Y115F (30% vs 0.6%; p<0.001), and L74VI (56% vs 1.8%; p<0.001). Among the 490 LPV/r recipients, 55 (11%) had ≥1 LPV-resistance mutations including 45 (9.6%) with intermediate or high-level LPV resistance. Low (20 patients) and intermediate (3 patients) darunavir (DRV) cross resistance was present in 23 (4.6%) patients. Conclusions: Among patients experiencing virological failure on a first-line regimen containing two NRTI plus one NNRTI, the use of TDF in adults and ABC in children was associated with an increase in four major non- thymidine analogue mutations. In a minority of patients, LPV/r-use was associated with intermediate or high-level LPV resistance with predominantly low-level DRV cross-resistance.Stellenbosch University Open Access FundPublishers' Versio